in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Perrigo’s API business reports lower operating profits
1:29 AM MDT | August 19, 2013 | Deepti Ramesh
The active pharmaceutical ingredients (API) business of health-care products firm Perrigo (Allegan, MI) reports a 6.5% rise in sales in the company’s fourth quarter, ended 29 June 2013, compared with the year-ago quarter, to $40.9 million. Operating profits for the API business decreased 42.8% in the fourth quarter, to $10 million. The API segment's fourth-quarter sales increased due primarily to the product mix, but it was offset by increased competition on specific products, Perrigo says. Fourth quarter margins in the API business were impacted by lower...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee